Skip to content

The Application Value of Spectral CT in the Accurate Staging of Gastric Cancer

The Application Value of Spectral CT in the Accurate Staging of Gastric Cancer

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06977386
Enrollment
150
Registered
2025-05-18
Start date
2025-06-01
Completion date
2026-05-31
Last updated
2025-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Brief summary

Spectral CT was used to prospectively collect medical images and clinical data related to gastric cancer, evaluate the effect of image quality in the diagnosis of gastric cancer, and evaluate the application value in the accurate staging of gastric cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.

Interventions

DIAGNOSTIC_TESTTo explore the value of spectral CT in the diagnosis and treatment of gastric cancer

CT scan of the abdomen outside of standard treatment options

Sponsors

Yunnan Cancer Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* (a)Patients with pathologically confirmed gastric cancer; * (b) aged ≥ 18 years old; * (c) have not received chemoradiotherapy or surgery.

Exclusion criteria

* (a)Combined with other primary tumors; * (b) The image quality does not meet the diagnostic criteria; * (c)Those who cannot tolerate CT examination.

Design outcomes

Primary

MeasureTime frameDescription
Pathological TNM staging1 dayPathological examination information: The pathology results using surgery/biopsy data are the gold standard, and the depth of tumor invasion, lymph node metastasis, and distant metastasis are recorded

Countries

China

Contacts

Primary ContactRuiling Yang
20231287@kmmu.edu.cn17390212095
Backup Contactzhenhui Li
lizhenhui@kmmu.edu.cn13698736132

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026